Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.
GLP-1 Drugs: New Questions on Mental Health and Sarcopenia GLP-1 receptor agonists show promise beyond obesity but require careful use due to sarcopenia risk and complex effects on mental health.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results